What is the appropriate griseofulvin dosage for a child weighing 21.32 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Griseofulvin Dosage for a 21.32 kg Child

For a child weighing 21.32 kg, administer griseofulvin 15-20 mg/kg/day (320-426 mg daily) as a single or divided dose for 6-8 weeks. 1

Specific Dosing Calculation

  • Standard dose range: 15-20 mg/kg/day
  • For 21.32 kg child:
    • Minimum: 320 mg/day (15 mg/kg)
    • Maximum: 426 mg/day (20 mg/kg)
  • Duration: 6-8 weeks initially
  • Administration: Single or divided doses, preferably with fatty food to enhance absorption 1

Important Dosing Considerations

Species-specific adjustments matter significantly:

  • For Microsporum infections (M. canis, M. audouinii): Standard 15-20 mg/kg/day is typically effective with 88.5% response rates 1
  • For Trichophyton infections (T. tonsurans, T. violaceum): May require higher doses up to 25 mg/kg/day for more prolonged periods (12-18 weeks) due to lower efficacy (67.9% response rates) 1

Recent evidence suggests even higher doses may be beneficial: A 2023 study found that refugee children with Trichophyton violaceum who showed partial response to ≤25 mg/kg/day achieved complete response when the dose was increased to ≥30 mg/kg/day, without significant adverse effects 2

Administration Tips

  • Give with fatty meals or milk: This significantly enhances absorption. In pediatric patients, griseofulvin given with milk resulted in 4-fold higher peak serum concentrations and 10-fold larger area under the curve compared to fasting administration 3
  • Formulation: Tablets are standard (suspension no longer licensed in UK but may be available elsewhere) 1

Treatment Duration Algorithm

  1. Initial treatment: 6-8 weeks at 15-20 mg/kg/day
  2. If clinical improvement but positive mycology at 6-8 weeks: Continue current therapy for additional 2-4 weeks 1
  3. If no clinical improvement: Consider treatment failure and switch to second-line therapy
  4. For Trichophyton species with poor response: Increase to 25 mg/kg/day and extend duration to 12-18 weeks 1

Critical Pitfalls to Avoid

  • Don't underdose: The British Association of Dermatologists explicitly recommends 15-20 mg/kg/day, not the lower 10 mg/kg/day sometimes used historically 1
  • Don't stop at clinical cure alone: The endpoint is mycological cure (negative culture and microscopy), not just clinical improvement. Repeat mycology sampling is essential 1
  • Don't assume all tinea capitis responds equally: Griseofulvin is significantly more effective against Microsporum (88.5%) than Trichophyton species (67.9%) 1

Contraindications and Drug Interactions

Absolute contraindications 1:

  • Porphyria
  • Hepatocellular failure/severe liver disease
  • Lupus erythematosus
  • Pregnancy (teratogenic)

Key drug interactions 1:

  • Rifampicin decreases griseofulvin levels
  • Cimetidine increases griseofulvin levels
  • May reduce efficacy of oral contraceptives

Monitoring

  • Baseline: Confirm diagnosis with microscopy and culture before or immediately after starting treatment 1
  • Follow-up: Repeat mycology sampling until mycological clearance achieved 1
  • Duration: Treatment may need extension beyond 8 weeks based on species and clinical response

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.